Fetal overgrowth in pregnancies complicated by diabetes: validation of a predictive index in an external cohort.

Autor: Tomlinson TM; Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Women's Health, Saint Louis University School of Medicine, 6420 Clayton Road, Suite 2800, Saint Louis, MO, 63117, USA. tracy.tomlinson@health.slu.edu., Johnson AM; Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Women's Health, Saint Louis University School of Medicine, 6420 Clayton Road, Suite 2800, Saint Louis, MO, 63117, USA., Edwards AM; Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Women's Health, Saint Louis University School of Medicine, 6420 Clayton Road, Suite 2800, Saint Louis, MO, 63117, USA., Gross GA; Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Women's Health, Saint Louis University School of Medicine, 6420 Clayton Road, Suite 2800, Saint Louis, MO, 63117, USA., Mostello DJ; Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Women's Health, Saint Louis University School of Medicine, 6420 Clayton Road, Suite 2800, Saint Louis, MO, 63117, USA.
Jazyk: angličtina
Zdroj: Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2021 Apr; Vol. 303 (4), pp. 877-884. Date of Electronic Publication: 2020 Sep 08.
DOI: 10.1007/s00404-020-05768-z
Abstrakt: Purpose: To assess validity of a fetal overgrowth index in an external cohort of women with diabetes in pregnancy METHODS: We performed a retrospective analysis of data derived from women with singleton gestations complicated by diabetes who delivered January 2015-June 2018. The following index variables were used to calculate risk of fetal overgrowth as defined by a customized birthweight ≥ 90th centile: age, history of fetal overgrowth in a prior pregnancy, gestational weight gain, fetal abdominal circumference measurement and fasting glucose between 24 and 30 weeks.
Results: In our validation cohort, 21% of 477 pregnancies were complicated by fetal overgrowth. The predictive index had a bias-corrected bootstrapped area under receiver operating characteristic curve of 0.90 (95% CI 0.86-0.93). 55% of the cohort had a low-risk index (≤ 3) which had a negative predictive value of 97% (95% CI 94-98%), while 18% had a high-risk index (≥ 8) that had a positive predictive value of 74% (95% CI 66-81%).
Conclusion: The fetal overgrowth index incorporates five factors that are widely available in daily clinical practice prior to the period of maximum fetal growth velocity in the third trimester. Despite substantial differences between our cohort and the one studied for model development, we found the performance of the index was strong. This finding lends support for the general use of this tool that may aid counseling and allow for targeted allocation of healthcare resources among women with pregnancies complicated by diabetes.
Databáze: MEDLINE
Externí odkaz: